Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients
Deng, Rong, Wang, Yehong, Maia, Mauricio, Burgess, Tracy, McBride, Jacqueline M., Liao, X. Charlene, Tavel, Jorge A., Hanley, William D.Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01108-17
Date:
November, 2017
File:
PDF, 889 KB
english, 2017